|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Jul―11 |
Accelerated phase development in a late-onset adolescent Chediak-Higashi syndrome patient caused by compound novel LYST mutations in the setting of SARS-CoV-2 infection |
Ping Guo, Xi Wu, Mingkang Yang, Yilun Xue, Jiakuan Zhou, Zhixi Huang, Wenman Wu, Jianbiao Wang |
2 |
[GO] |
2024―Apr―26 |
Extreme γ′ fibrinogen levels in COVID-19 patients |
Matthew Hudkins, Heather Hamilton, Samantha J. Underwood, Diana E. Kazmierczak, Elizabeth N. Dewey, Steven C. Kazmierczak, William B. Messer, Akram Khan, Martin A. Schreiber, David H. Farrell |
3 |
[GO] |
2024―Jan―21 |
Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity |
Lucy Z. Kornblith, Bindhya Sadhanandhan, Sreepriya Arun, Rebecca Long, Alicia J. Johnson, Jamie Noll, C.N. Ramchand, John K. Olynyk, David H. Farrell |
4 |
[GO] |
2024―Jan―17 |
Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity |
Sangsang Wang, Diao Yu, Junwu Zhang |
5 |
[GO] |
2023―Jul―20 |
Genetic examination of hematological parameters in SARS-CoV-2 infection and COVID-19 |
Quan Sun, Bryce Rowland, Wanjiang Wang, Tyne W. Miller-Fleming, Nancy Cox, Misa Graff, Annika Faucon, Megan M. Shuey, Elizabeth E. Blue, Paul Auer, Yun Li, Vijay G. Sankaran, Alexander P. Reiner, Laura M. Raffield |
6 |
[GO] |
2023―May―20 |
Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race |
Jennifer K. Frediani, Ezra Pak-Harvey, Richard Parsons, Adrianna L. Westbrook, William O'Sick, Greg S. Martin, Wilbur A. Lam, Joshua M. Levy |
7 |
[GO] |
2023―Apr―29 |
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity |
Lucy Z. Kornblith, Bindhya Sadhanandhan, Sreepriya Arun, Rebecca Long, Alicia J. Johnson, Jamie Noll, C.N. Ramchand, John K. Olynyk, David H. Farrell |
8 |
[GO] |
2022―Jun―03 |
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing |
Han Bai, Junpeng Ma, Weikang Mao, Xuan Zhang, Yijun Nie, Jingcan Hao, Xiaorui Wang, Hongyu Qin, Qiqi Zeng, Fang Hu, Xin Qi, Xiaobei Chen, Dong Li, Binghong Zhang, Bingyin Shi, Chengsheng Zhang |
9 |
[GO] |
2022―May―29 |
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients |
Elham Jamali, Mojdeh Abbasi, Akbar Hashemi Tayer, Ali Arabi Monfared, Parisa Tandel, Gholamhossein Tamaddon, Ehsan Sarraf Kazerooni, Shahrokh Rakhshandehroo, Reza Ranjbaran |
10 |
[GO] |
2022―Feb―11 |
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients |
Simrandeep Kaur, Anamika Singh, Jaskaran Kaur, Nikhil Verma, Anil K. Pandey, Suman Das, Sankar Bhattacharyya, Prasenjit Guchhait |
11 |
[GO] |
2021―Dec―30 |
Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination |
Kawthar Jarrah, Layal Al Mahmasani, Ali Atoui, Rayan Bou-Fakhredin, Ali T. Taher |
12 |
[GO] |
2021―Nov―17 |
Prognostic factors associated with COVID-19 related severity in sickle cell disease |
Nalan Yurtsever, Vijay Nandi, Yonah Ziemba, Patricia A. Shi |
13 |
[GO] |
2021―Oct―08 |
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature |
Gardellini Angelo, Guidotti Francesca, Maino Elena, Steffanoni Sara, Zancenella Michelle, Turrini Mauro |
14 |
[GO] |
2021―Sep―09 |
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study |
Louise F. Kimura, Morena B. Sant'Anna, Sonia A. Andrade, Matteo C. Ebram, Cristiane F.G. Lima, Rosa M.G. Celano, Ruy F.M. Viégas, Gisele Picolo |
15 |
[GO] |
2021―Apr―21 |
ABO blood groups, COVID-19 infection and mortality |
Steven Lehrer, Peter H. Rheinstein |
16 |
[GO] |
2021―Feb―19 |
Effectiveness of convalescent plasma in Indian patients with COVID-19 |
Sandeep Budhiraja, Arun Dewan, Ritesh Aggarwal, Omender Singh, Deven Juneja, Sangeeta Pathak, Y.P. Singh, Ajay Gupta, Reeta Rai, Abhaya Indrayan, Vinitaa Jha, Rahul Naithani |
17 |
[GO] |
2020―Dec―08 |
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies |
Pronamee Borah, Sumeet Mirgh, Sanjeev Kumar Sharma, Sachin Bansal, Ashish Dixit, Tuphan Kanti Dolai, Sweta Lunkad, Naveen Gupta, Gurmeet Singh, Aditi Jain, Divya Bansal, Dharma Choudhary, Vipin Khandelwal, Divya Doval, Meet Kumar, Rahul Bhargava, Amrita Chakrabarti, Mallikarjun Kalashetty, Amit Rauthan, Bilal Kazi, Prakas Kumar Mandal, Preethi Jeyaraman, Rahul Naithani |
18 |
[GO] |
2020―Jul―24 |
Potential ‘significance’ of monoclonal gammopathy of ‘undetermined significance’ during COVID-19 pandemic |
Ankur Jain, Karthik Ramasamy |
19 |
[GO] |
2020―Jul―14 |
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies? |
Marcio Andrade-Campos, Beatriz Escuder-Azuara, Laura López de Frutos, Irene Serrano-Gonzalo, Pilar Giraldo |
20 |
[GO] |
2020―Apr―14 |
Increased expression of CD8 marker on T-cells in COVID-19 patients |
Ali Ganji, Iman Farahani, Behzad Khansarinejad, Ali Ghazavi, Ghasem Mosayebi |
21 |
[GO] |
2020―Apr―11 |
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians |
Kamal Kant Sahu, Vishal Jindal, Ahmad Daniyal Siddiqui, Jan Cerny |